Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

valeant_web

Valeant seeks clean slate with rebrand, new company name

May 9, 2018 Medical Communications, Research and Development Valeant, pharma

In the latest attempt to reverse its ailing fortunes and distance itself from its polluted brand, Canadian pharma firm Valeant …
News
bald_man

Old osteoporosis drug could be used to treat hair loss

May 9, 2018 Research and Development biotech, drugs, hair loss, pharma, pharmaceutical

Researchers from the University of Manchester’s Centre for Dermatology Research have made a breakthrough towards the holy grail of the …
News
faron_share

Faron’s stock freefalls by 80% after key drug failure

May 9, 2018 Research and Development ARDS, Faron, acute respiratory distress syndrome, pharma, traumakine

Faron Pharmaceuticals has seen its share price plummet by more than 80% after it emerged that its recombinant human interferon …
News
michael_cohen

Novartis caught in the Stormy Daniels affair, after huge payment to Trump’s lawyer

May 9, 2018 Medical Communications, Research and Development Cohen, Novartis, President trump, Trump, biotech, drugs, pharma, pharmaceutical

Novartis has suddenly found itself embroiled in the Stormy Daniels affair, after the lawyer representing her, Michael Avenatti, included the …
News
credit_-_daniel_leal-olivas-afp

European approval for tablet formulation of Lynparza in ovarian cancer

May 8, 2018 Research and Development, Sales and Marketing AstraZeneca, Cancer, EMA, Europe, MSD, lynparza, ovarian cancer, pharma

AstraZeneca and MSD’s poly ADP-ribose polymerase (PARP) inhibitor Lynparza (olaparib) has been approved for use in Europe, it has emerged, …
News
eye

All eyes on dry eye disease

May 8, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing TopiVert, dry eye disease, eye, pharma

Dr Matthew Fyfe, Head of Chemistry and Intellectual Property at TopiVert, gives an illuminating look into the latest developments in …
Feature
jj

J&J’s ketamine-based antidepressant showed mixed success at Phase 3

May 8, 2018 Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, Ketamine, antidepressant, depression, esketamine, pharma

Johnson & Johnson has revealed new data on its new depression drug esketamine, its chemically ‘left-handed’ version of the controlled …
News
top_ten

Top Ten most popular articles on Pharmafile.com this week

May 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, EMA, Kymriah, Novartis, Porton Biopharma, Regeneron, Roche, Sandoz, Sanofi, Shire, Takeda, biosimilars, dementia

It’s Friday again and it’s been a week busy with companies’ financials. One company’s in particular were of note due …
News
webinar

Free webinar – Rational EU risk management for oncology medicines

May 4, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NDA Group, biotech, drugs, pharma, pharmaceutical

It is timely to reflect on how we can best implement the revised GVP module (V) concerning risk management in …
News
sugar_tax

The UK sugar tax: A sweet or sour move?

May 3, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, obesity, pharma, sugar tax

Dr Daniel Bailey, Senior Lecturer in Health, Nutrition and Exercise at the University of Bedfordshire, discusses the benefits of the …
Feature
nerves

New study argues the importance of existing anti-inflammatory drugs in fighting dementia

May 3, 2018 Research and Development Alzheimer's, dementia, pharma

Research into dementia has waned in recent times as researchers struggle to pin down concrete advancements, leading to the withdrawal …
News
ecstasy_monogram

Recreational drug MDMA proves efficacy in reducing PTSD symptoms, new study finds

May 3, 2018 Research and Development MDMA, PTSD, pharma

Promising new findings have been revealed in the efficacy of MDMA in treating post-traumatic stress disorder (PTSD).
News

BMS pulls the plug on Phase 3 trials of IDO1 inhibitor

May 2, 2018 Research and Development BMS, Bristol-Myers Squibb, IDO1, opdivo, pharma, phase 3

Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor acquired through its $800 million acquisition …
News
20170628182643b6d1090b2-8235-4860-8281-743f52e15ed4

Samsung BioLogics’ shares down $6bn after accounting furore

May 2, 2018 Research and Development, Sales and Marketing Samsung BioLogics, Samsung Bioepis, biotech, drugs, pharma, pharmaceutical, south korea

Samsung BioLogics’ shares have been hit hard, after the South Korean company was handed a notice of suspected breach of …
News
aaron_traywick

Startup CEO who injected untested herpes cure during live stream found dead

May 2, 2018 Research and Development Aaron Traywick, Ascendance Biomedical, HIV, herpes, pharma

Aaron Traywick, the 28-year-old CEO of biotech startup Ascendance Biomedical who made headlines when he injected himself with an untested …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026